US 9220748
Macrocyclic proline derived HCV serine protease inhibitors
granted A61KA61K38/00A61K38/12
Quick answer
US patent 9220748 (Macrocyclic proline derived HCV serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61K38/12, A61K38/212, A61K38/215